[Development of a Series of Neutralizing Nanobodies against SARS-CoV-2 Spike Protein].
Mol Biol (Mosk)
; 57(3): 505-516, 2023.
Article
in Ru
| MEDLINE
| ID: mdl-37326055
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Single-Domain Antibodies
/
COVID-19
Limits:
Humans
Language:
Ru
Journal:
Mol Biol (Mosk)
Year:
2023
Document type:
Article